NSF Short-Circuits Electronic Submissions Project

WASHINGTON—Why, wondered Erich Bloch soon after he became director of the National Science Foundation in 1984, couldn’t scien tists submit their grant proposals to NSF electronically? What Bloch had in mind was a gradual shift of the entire grants process—from the development of a proposal through its review by a panel of outside experts—from brown paper envelopes to phone circuits. Spurred by that clear vision, NSF drew up plans, solicited proposals, and in October19

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—Why, wondered Erich Bloch soon after he became director of the National Science Foundation in 1984, couldn’t scien tists submit their grant proposals to NSF electronically? What Bloch had in mind was a gradual shift of the entire grants process—from the development of a proposal through its review by a panel of outside experts—from brown paper envelopes to phone circuits.

Spurred by that clear vision, NSF drew up plans, solicited proposals, and in October1986 launched a project known as EXPRES (EXP erimental Research in Electronic Submission).

But the answer to Bloch’s question, it turns out, is far from simple. Two and one-half years after NSF made identical three-year, $3 million grants to the University of Michigan and Carnegie Mellon University to develop electronic methods of handling such documents, foundation officials have realized that EXPRES is falling far short of its lofty goals. In an effort to cut its losses, NSF ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies